SC 13D

Company

Tempest Therapeutics, Inc.

Filed

May 9, 2022

Accession Number

0001193125-22-145151

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →